Login / Signup

A systematic review and meta-analysis of beta-blockers and renin-angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer.

Christian LewinterTorsten Holm NielsenLars Robert EdforsCecilia LindeJohn Martin BlandM LeWinterJohn G F ClelandLars Valeur KøberFrieder BraunschweigAgneta Mansson-Broberg
Published in: European heart journal (2022)
Both BB and ACEI/ARB therapies were associated with the preservation of LVEF during trastuzumab and anthracycline-containing regimens as compared with placebo, suggesting both to be beneficial.
Keyphrases